mardi 21 janvier 2020

Onco Actu du 21 janvier 2020


1.1 BIOLOGIE - GÉNOME



New tumour-driving mutations discovered in the under-explored regions of the cancer genome [OICR]











3.1.1 PRÉVENTION - TABAC - E-CIGS



We don’t need to ban vaping. We need to build better vaping devices [STAT]










4.12 BIOPSIES LIQUIDES



Glass half full: Improving outcomes in patients with circulating tumor DNA molecular residual disease [Nature Cancer Community]











4.9 DÉP., DIAG. & PRONO. - SEIN



Magnetised molecules used to monitor breast cancer [Cancer Research UK]











Refining Breast Cancer Classification by Multiplexed Imaging [University of Zurich]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Dozens of non-oncology drugs can kill cancer cells [Broad Institute]










5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Immune cell which kills most cancers discovered by accident by British scientists in major breakthrough [The Telegrah]











Discovery of new T-cell raises prospect of ‘universal’ cancer therapy [Cardiff University]










Immune discovery 'may treat all cancer' [BBC News]











5.12.13 IMMUNOTHÉRAPIES - BIOMARQUEURS



New Technique Predicts Which Melanoma Patients Are at Risk for Cancer Recurrence and Spread [Brigham Health]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma [Roche]











5.4 TRAITEMENTS - ECONOMIE



Hormone therapy now available for newly diagnosed prostate cancer in Scotland [Cancer Research UK]











6.6 PUBLICATIONS, POLITIQUES SCIENTIFIQUES



CRediT Check – Should we welcome tools to differentiate the contributions made to academic papers? [LSE Impact Blog]











6.7 DMP, BIG DATA & APPLIS



EMA, HMA Set 10 Priorities for Big Data [RAPS]











Ten recommendations to unlock the potential of big data for public health in the EU [EMA]